These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 22689282)

  • 1. [Optimizing antidepressant pharmacotherapy in a case of inflammatory bowel disease and major depression].
    Schmidt FM; Tennert C; Teupser D; Himmerich H
    Psychiatr Prax; 2012 Jul; 39(5):239-42. PubMed ID: 22689282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A risk-benefit assessment of mirtazapine in the treatment of depression.
    Kasper S; Praschak-Rieder N; Tauscher J; Wolf R
    Drug Saf; 1997 Oct; 17(4):251-64. PubMed ID: 9352961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lithium but not carbamazepine augments antidepressant efficacy of mirtazapine in unipolar depression: an open-label study.
    Schüle C; Baghai TC; Eser D; Nothdurfter C; Rupprecht R
    World J Biol Psychiatry; 2009; 10(4 Pt 2):390-9. PubMed ID: 18609420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mirtazapine-induced manic switch in adolescent unipolar depression.
    Goyal N; Sinha VK
    Aust N Z J Psychiatry; 2008 Dec; 42(12):1070-1. PubMed ID: 19031640
    [No Abstract]   [Full Text] [Related]  

  • 5. Mirtazapine-associated dose-dependent and asymptomatic elevation of hepatic enzymes.
    Adetunji B; Basil B; Mathews M; Osinowo T
    Ann Pharmacother; 2007 Feb; 41(2):359. PubMed ID: 17244643
    [No Abstract]   [Full Text] [Related]  

  • 6. Multicenter study on the clinical effectiveness, pharmacokinetics, and pharmacogenetics of mirtazapine in depression.
    Jaquenoud Sirot E; Harenberg S; Vandel P; Lima CA; Perrenoud P; Kemmerling K; Zullino DF; Hilleret H; Crettol S; Jonzier-Perey M; Golay KP; Brocard M; Eap CB; Baumann P
    J Clin Psychopharmacol; 2012 Oct; 32(5):622-9. PubMed ID: 22926595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mirtazapine for depression in patients with human immunodeficiency virus.
    Elliott AJ; Roy-Byrne PP
    J Clin Psychopharmacol; 2000 Apr; 20(2):265-7. PubMed ID: 10770469
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment-refractory depression successfully treated with the combination of mirtazapine and lithium.
    Moustgaard G
    J Clin Psychopharmacol; 2000 Apr; 20(2):268. PubMed ID: 10770470
    [No Abstract]   [Full Text] [Related]  

  • 9. Mirtazapine for treatment-resistant depression: a preliminary report.
    Wan DD; Kundhur D; Solomons K; Yatham LN; Lam RW
    J Psychiatry Neurosci; 2003 Jan; 28(1):55-9. PubMed ID: 12587851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-administration of mirtazapine could overcome previous mirtazapine- associated restless legs syndrome?
    Pae CU; Kim TS; Kim JJ; Chae JH; Lee CU; Lee SJ; Paik IH; Lee C
    Psychiatry Clin Neurosci; 2004 Dec; 58(6):669-70. PubMed ID: 15601394
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute reversible dyskinesia induced by mirtazapine.
    Konitsiotis S; Pappa S; Mantas C; Mavreas V
    Mov Disord; 2005 Jun; 20(6):771. PubMed ID: 15732128
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute Pisa syndrome after administration of a single dose of mirtazapine.
    Méndez Guerrero A; Llamas S; Murcia FJ; Ruíz J
    Clin Neuropharmacol; 2013; 36(4):133-4. PubMed ID: 23783006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High mirtazapine plasma levels in infant after breast feeding: case report and review of the literature.
    Tonn P; Reuter SC; Hiemke C; Dahmen N
    J Clin Psychopharmacol; 2009 Apr; 29(2):191-2. PubMed ID: 19512989
    [No Abstract]   [Full Text] [Related]  

  • 14. Venlafaxine, but not mirtazapine lowers retinol-binding protein 4 serum concentrations in nondiabetic depressed patients.
    Deuschle M; Angermeier T; Westphal S; Lederbogen F; Gilles M; Frankhauser P; Schilling C; Onken V; Weber-Hamann B; Kopf D
    Psychother Psychosom; 2010; 79(2):123-5. PubMed ID: 20090399
    [No Abstract]   [Full Text] [Related]  

  • 15. Sertraline- and mirtazapine-induced severe neutropenia.
    Ozcanli T; Unsalver B; Ozdemir S; Ozmen M
    Am J Psychiatry; 2005 Jul; 162(7):1386. PubMed ID: 15994730
    [No Abstract]   [Full Text] [Related]  

  • 16. Mirtazapine and restless leg syndrome: a case report.
    Bonin B; Vandel P; Kantelip JP
    Therapie; 2000; 55(5):655-6. PubMed ID: 11201984
    [No Abstract]   [Full Text] [Related]  

  • 17. Mirtazapine-induced hepatocellular-type liver injury.
    Kang SG; Yoon BM; Park YM
    Ann Pharmacother; 2011 Jun; 45(6):825-6. PubMed ID: 21666084
    [No Abstract]   [Full Text] [Related]  

  • 18. Hyperglycaemia secondary to mirtazapine therapy in a 37-year-old man.
    Chen R; Lopes J
    Aust N Z J Psychiatry; 2008 Nov; 42(11):990-1. PubMed ID: 18946939
    [No Abstract]   [Full Text] [Related]  

  • 19. Mirtazapine and hyperpigmentation.
    Mendhekar D; Inamdar A
    World J Biol Psychiatry; 2009; 10(4 Pt 2):688-9. PubMed ID: 19404867
    [No Abstract]   [Full Text] [Related]  

  • 20. A case of pulmonary thromboembolism and rhabdomyolysis during therapy with mirtazapine and risperidone.
    Zink M; Knopf U; Argiriou S; Kuwilsky A
    J Clin Psychiatry; 2006 May; 67(5):835. PubMed ID: 16841636
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.